XiaoMi-AI文件搜索系统
World File Search Systemupcoming
Argent LNG 选择 Chart Industries 的 IPSMR® 工艺技术
选择 Chart Industries（纽约证券交易所股票代码：GTLS）的中型模块化液化解决方案作为其即将推出的战略决策
请求表达兴趣（EOI）
DESCRIPTION OF REQUIREMENTS The United Nations Office at Nairobi (UNON), on behalf of United Nations Environment Programme (UNEP) invites qualified interested firms to submit Expression of Interest (EOI) to participate in the upcoming solicitation for the Assessment to develop debt for nature and climate swaps and other innovative instruments to finance forest landscape restoration and conservation in the Sistema de la Integración Centroamericana (SICA) 地区。评估区将包括伯利兹，哥斯达黎加，多米尼加共和国，埃尔萨尔瓦多，危地马拉，危地马拉，洪都拉斯，尼加拉瓜和巴拿马。这项研究将成为开发全绿色气候基金计划计划的准备研究的一部分，标题为“为“改善和米尔特林业的改装和米特林”统治''中美洲伟大的森林计划旨在在中美洲和多米尼加共和国对森林保护和气候韧性进行变革性转变。通过对机构和监管框架结盟和加强，并通过协调保护，恢复和自然阳性业务的协调投资加速创新融资，该计划旨在提高土著人民和地方社区（IPLC）的适应能力和适应能力（IPLC）（IPLC）（IPLC）（IPLC）（IPLC），降低CO2的二氧化碳和保护森林森林森林生物元。
临床神经生理学
目的：本研究旨在探索亚急性脊髓损伤 (SCI) 患者运动想象 (MI) 期间的皮质激活及其侧化是否预示着中枢神经性疼痛 (CNP) 的出现或即将出现。方法：在四组参与者的双手 MI 期间记录多通道脑电图：健全 (N = 10)、SCI 和 CNP (N = 11)、在 EEG 记录后 6 个月内出现 CNP 的 SCI (N = 10) 和无 CNP 的 SCI (N = 10)。在横跨感觉运动皮层和疼痛基质的 20 个区域中的四个频带中得出源激活及其侧化。结果：在运动前皮质的 θ 波段（即将发生的 CNP 与现有的 CNP，p = 0.036）、岛叶的 α 波段（健康与即将发生的 CNP，p = 0.012）以及体感联想皮质的较高 β 波段（无 CNP 与即将发生的 CNP，p = 0.042）中发现侧化存在统计学上的显著差异。与无 CNP 的人相比，即将发生的 CNP 的人在双手 MI 的较高 β 波段中具有更强的激活。结论：MI 期间疼痛相关区域的激活强度和侧化可能对 CNP 具有预测价值。意义：该研究增加了对 SCI 中从无症状到有症状的早期 CNP 转变机制的理解。2023 年国际临床神经生理学联合会。由 Elsevier BV 出版 这是一篇根据 CC BY 许可 ( http://creativecommons.org/licenses/by/4.0/ ) 开放获取的文章。
Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release
window of the product, as illustrated by several studies. 2 – 12 In the ADC eld, site-speci c technologies of all types now domi- nate new ADCs entering into clinical trials. However, the recent work of ImmunoGen comparing homogenous and heteroge- nous ADCs that generate the same metabolites, suggests that site-speci c technologies may not always enhance the phar- macokinetics of the drug and may also detrimentally alter its toxicity pro le. 13 – 15 In fact, several criteria such as the nature of the payload, the linker, the conjugation chemistry, the drug- antibody ratio (DAR), the hydrophobicity of the ADC may have an impact on the in vivo properties of the conjugate, which are for the time being di ffi cult to predict. The large number of upcoming clinical studies of site-speci cally prepared ADCs may help clarifying if there is a single conjugation chemistry that will become of widespread use, or whether other methods will also be applicable. Therefore, developing various technol- ogies is of interest for further progress in the eld. Site-speci c conjugation to an antibody is challenging due to the large number of solvent-exposed nucleophilic amino acids, in particular lysines. Despite this di ffi culty, the eld has been very proli c through developing a wide array of technologies that can be summarized as engineered cysteines, disul de
